Cancer Family

Lymphocytic Neoplasm

HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items

NCIt: C7065

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (351)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 351 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.
Kylee H Maclachlan, Marios Papadimitriou, Patrick Blaney et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42284538 · candidate dictionary pubmed
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.
Maximilian Merz, Tomas Jelinek, Thomas Pabst et al. · Blood Cancer Discov · Sep 3, 2026 · PMID 42284467 · candidate dictionary pubmed
A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study.
Song Jin, Zhaohui Liao, Shuang Yan et al. · Blood · Sep 3, 2026 · PMID 42275247 · candidate dictionary pubmed
Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.
Susan Bal, Myo Htut, Omar Nadeem et al. · Blood · Sep 3, 2026 · PMID 42233419 · candidate dictionary pubmed
Correlations between autograft cellular components and post-transplant outcome in patients with systemic non-Hodgkin lymphoma mobilized with on-demand plerixafor: A prospective multicenter GOA study.
Anu Partanen, Antti Turunen, Outi Kuittinen et al. · Transfus Apher Sci · Sep 2, 2026 · PMID 42700534 · candidate dictionary pubmed
Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.
Julia Wang, Yajuan Gao, Spears M Grant et al. · Br J Haematol · Sep 1, 2026 · PMID 42676284 · candidate dictionary pubmed

Response to Comment on: "Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?".

Eldad J Dann · Haematologica · Sep 1, 2026 · PMID 42206426 · candidate dictionary pubmed

Characterization of JNJ-80948543 a novel CD79bxCD20xCD3 trispecific antibody for B-cell non-Hodgkin lymphoma.

Anna Kuchnio, Danlin Yang, Nele Vloemans et al. · Haematologica · Sep 1, 2026 · PMID 41742895 · candidate dictionary pubmed

Surveillance Strategies in Follicular Non-Hodgkin's Lymphoma's Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies.

Cherian Verghese, Kapil Meleveedu, Urja Nagadia et al. · Am J Clin Oncol · Sep 1, 2026 · PMID 41698176 · candidate dictionary pubmed

Predicting long-term absolute risk of lung cancer in patients with Hodgkin lymphoma.

Shahin Roshani, Naomi B Boekel, Flora E Van Leeuwen et al. · J Natl Cancer Inst · Sep 1, 2026 · PMID 41942100 · candidate dictionary pubmed

Role of 18F-FDG PET/CT Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis.

Hatice Uysal, Aziz Gültekin, Nil Güler et al. · Turk J Haematol · Sep 1, 2026 · PMID 41699841 · candidate dictionary pubmed

Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience.

Kristin C Marr, Terry Tang, Jonathan Simkin et al. · Haematologica · Sep 1, 2026 · PMID 41063706 · candidate dictionary pubmed

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratory measurements, and treatment history.

Shangru Jia, Artem Lysenko, Keith A Boroevich et al. · Brief Bioinform · Sep 1, 2026 · PMID 42704271 · candidate dictionary pubmed

Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.

Oliver Henriques Peck, Aimee McCoubrey, John A Snowden et al. · Open Heart · Sep 1, 2026 · PMID 42680232 · candidate dictionary pubmed

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

Darren Pan, Anupama Kumar, Jodi J Lipof et al. · Cancer · Sep 1, 2026 · PMID 42675812 · candidate dictionary pubmed

Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

F Lennie Wong, Scott R Goldsmith, Kimlin Ashing et al. · Cancer · Sep 1, 2026 · PMID 42663244 · candidate dictionary pubmed

Methylation variability and LINE-1 transcriptional activation in multiple myeloma.

Qianhui Wan, Amy Leung, Mahek Vinod Bhandari et al. · Genome Res · Sep 1, 2026 · PMID 42469014 · candidate dictionary pubmed

Establishment of a Multimodal Prognostic Prediction Model for Multiple Myeloma Patients Based on Radiomics and Clinical Features: A Retrospective Cohort Study.

Shiqi Sun, Zejing Huang, Yunlong Tang et al. · Turk J Haematol · Sep 1, 2026 · PMID 42460671 · candidate dictionary pubmed

Dural Follicular Non-Hodgkin Lymphoma Mimicking a Chronic Subdural Hematoma: A Case Report and Literature Review.

Carlos A Arellanes-Chavez, Ernesto Ramos Mertinez · Cureus · Sep 1, 2026 · PMID 42703457 · candidate dictionary pubmed

CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.

Marie José Kersten, Maria T Kuipers, Pim G N J Mutsaers et al. · Lancet Haematol · Sep 1, 2026 · PMID 42660131 · candidate dictionary pubmed

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.

Peiqi Zhao, Yihan Wang, Min Bai et al. · Am J Hematol · Sep 1, 2026 · PMID 42590970 · candidate dictionary pubmed

Optimising survivorship care in Hodgkin's lymphoma: Aligning practice with Ireland's AYA cancer framework.

Maeve Kearney, Sara Faithfull, Michelle Leech · J Cancer Policy · Sep 1, 2026 · PMID 42520965 · candidate dictionary pubmed

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials.

Mallorie B Heneghan, Lindsay A Renfro, Yue Wu et al. · Pediatr Blood Cancer · Sep 1, 2026 · PMID 42496647 · candidate dictionary pubmed

Primary Pulmonary Hodgkin Lymphoma: A Cytologic Diagnostic Challenge.

Nicholas Jin Hong Tan, Vanda F Torous · Diagn Cytopathol · Sep 1, 2026 · PMID 42415350 · candidate dictionary pubmed

Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Yuko Shirouchi, Yuko Mishima, Suguru Fukuhara et al. · Int J Clin Oncol · Sep 1, 2026 · PMID 42390726 · candidate dictionary pubmed